Back to Directory

Astragalus

Huang Qi, Milk-vetch root

Visual ViewRaw Data

Meta Information

ID:astragalus
Name:Astragalus
Schema Version:1.5

Alternate Names

  • Huang Qi
  • Milk-vetch root

Active Compound

Astragalosides, Polysaccharides

Intervention Type

therapeutic_agent

Delivery

Route:
oral
Scope:
  • systemic

Regulatory Status

  • us:dietary_supplement

Indication

Focus:
healthspan
Description:
Supports cellular health, immune function, and potential telomere maintenance.

Typical Protocol

  • Standardized extracts commonly use 250-500 mg, 1-3 times daily.
  • Raw dried root can be used in teas or decoctions at higher doses, typically 9-30 grams daily.

Expected Cost Mean

Low Cost:
15
High Cost:
40
Cost Type:
monthly
Description:
Cost for a typical monthly supply of astragalus extract.

Summary

Astragalus (Huang Qi) is a traditional Chinese medicinal herb. Its primary bioactive compounds, astragalosides and polysaccharides, are studied for their potential to support telomere length, enhance immune function, and provide antioxidant and anti-inflammatory effects. These mechanisms are relevant to delaying cellular senescence and improving overall cellular resilience and systemic function.

Purpose

Herbal adaptogen supporting cellular health and immune function for longevity.

Card Summary

Traditional herb studied for telomere, immune, and anti-inflammatory support.

Drug Class

null

Drugs In Class

Empty Array

Impact

Score:
4.5
Justification:
Supports cellular health and immunity; emerging telomere evidence.

Evidence

Grade:
C
Score:
4
Justification:
Primarily in-vitro/animal data; limited human healthspan RCTs.

Safety

Score:
3.5
Justification:
Generally well-tolerated; potential interactions with immunosuppressants.

Flags

  • May interact with immunosuppressant medications, anticoagulants, and blood pressure medications.
  • Use with caution in individuals with autoimmune conditions due to immune-stimulating properties.
  • Limited long-term safety data at high doses for healthspan applications.

Verdict

Modest immune and cellular support; not a primary healthspan driver.